Target intelligence / Profile preview

Ribosomal protein L21 pseudogene 24 (RPL21P24)

Target: RPL21P24
Molecular classification: Other (Processed pseudogene)

Overview

Ribosomal protein L21 pseudogene 24 (RPL21P24) is a processed pseudogene in the human genome, derived from the protein-coding parent gene RPL21. It arose through the reverse transcription of mRNA and subsequent integration of non-functional copies into the genome. Pseudogenes such as RPL21P24 do not encode functional proteins and lack biological or therapeutic activity. While its parent gene, ribosomal protein L21, is involved in ribosome assembly and protein synthesis, RPL21P24 itself is not expressed and has no known biological function or disease association.

Other names: RPL21_4_45RPL21P24

Beyond the preview

Go deeper on Ribosomal protein L21 pseudogene 24 (RPL21P24).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L21 pseudogene 24 (RPL21P24).

Explore the full profile